Trials / Completed
CompletedNCT01909557
Acetyl-L-Carnitine Supplementation During HCV Therapy With Peg IFN-α2b Plus Ribavirin: Effect on Work Performance.
Effect of Supplementation of Antioxidant Substances and Probiotics in HCV Correlated Liver Disease Treated With Interferon and Ribavirin. Studies on Biochemical and Virological Response and on Quality of Life.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 62 (actual)
- Sponsor
- University of Catania · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Accepted
Summary
To assess the effects of Acetyl-L-Carnitine, probiotics and antioxidant nutritional substances administration on work productivity, daily activity, and fatigue in subjects with chronic hepatitis C treated with Pegylated-Interferon-α2b and Ribavirin.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Acetyl-L-carnitine | |
| DRUG | placebo |
Timeline
- Start date
- 2010-01-01
- Primary completion
- 2011-12-01
- Completion
- 2011-12-01
- First posted
- 2013-07-26
- Last updated
- 2013-07-26
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT01909557. Inclusion in this directory is not an endorsement.